ACIP Presentation Slides: October 19-20, 2022 Meeting

Note: These files are not yet 508

Slides will be added as they become available.

October 19, 2022

Welcome & Introductions

• Introduction
  Dr. G Lee
  Dr. M Wharton

Pneumococcal Vaccines

• Introduction [15 pages]
  Dr. K Poehling
• Cost-effectiveness analysis of PCV20 use among adults who previously received PCV13 [39 pages]
  Dr. C Stoecker
• Summary of work group interpretation of EtR and proposed recommendations [87 pages]
  Dr. M Kobayashi
• Clinical Considerations [20 pages]
  Dr. M Kobayashi

Chikungunya Vaccines

• Introduction [7 pages]
  Dr. B Bell
• Overview of chikungunya and chikungunya vaccines [26 pages]
  Dr. S Hills
• Vaccine immunogenicity and safety [23 pages]
  Dr. K Dubischar
• Work group interpretation of vaccine data and activities [20 pages]
  Dr. S Hills

COVID-19 Vaccines

• Introduction [7 pages]
  Dr. M Daley
• COVID-19 in pregnant people and infants ages 0-5 months; COVID-19 vaccine safety in pregnancy; Effectiveness of maternal COVID-19 vaccination in pregnant [63 pages]
  Dr. S Ellington; Dr. C Olsen and Dr. E Kharbanda; Dr. K Fleming-Dutra
• COVID-19 vaccines in children [39 pages]
  Dr. S Oliver
• Vaccines for children [6 pages]
  Dr. J Santoli

Polio Vaccines

• Poliovirus and Vaccination [31 pages]
  Dr. K Dooling

October 20, 2022

Welcome & Introductions

• Introduction
  Dr. G Lee
  Dr. M Wharton

Agency Updates

Combined Immunization Schedule

• Introduction
  Dr. S Cineas
  
• 2023 child and adolescent schedule revisions; 2023 adult schedule revisions [157 pages]
  Dr. P Wodi; Dr. N Murthy

Respiratory Syncytial Virus (RSV) Vaccines – Older Adults

• Introduction [8 pages]
  Dr. C Kotton
• GSK safety & efficacy [24 pages]
  Dr. B Rizkalla
• Pfizer safety & efficacy [26 pages]
  Dr. A Gurtman
• WG considerations [20 pages]
  Dr. M Melgar

Respiratory Syncytial Virus (RSV) Vaccine – Maternal/Pediatric

• Introduction [6 pages]
  Dr. S Long
• Nirsevimab updated safety and efficacy [27 pages]
  Dr. C Felter
• WG considerations [6 pages]
  Dr. J Jones

Meningococcal Vaccines

• Introduction [12 pages]
  Dr. K Poehling
• Menveo Solution updates [12 pages]
  Dr. S Crowe
• Terms of reference for pentavalent vaccines [13 pages]
  Dr. S Crowe

Influenza Vaccines

• Introduction [4 pages]
  Dr. K Talbot
• Clinical Trial to Compare Safety of RIV4 Versus IIV4 in Pregnancy [22 pages]
  Dr. G Swamy
• Influenza Activity Update [16 pages]
  Ms. L Brammer and Dr. P Marcenac
• Influenza Vaccine Effectiveness Update [24 pages]
  Ms. J Chung, Ms. S Olson, and Dr. N Lewisc

Dengue Vaccines

• Introduction [7 pages]
  Dr. W Chen
• Dengue Epidemiology [37 pages]
  Dr. L Adams
• Review of Sanofi dengue vaccine and ACIP recommendations [29 pages]
  Dr. G Paz-Bailey

Monkeypox Vaccines

• Introduction [20 pages]
  Dr. P Sanchez